Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 Mar;111(3):787–792. doi: 10.1111/j.1476-5381.1994.tb14806.x

Studies on the mechanism of [3H]-noradrenaline release from SH-SY5Y cells: the role of Ca2+ and cyclic AMP.

R Atcheson 1, D G Lambert 1, R A Hirst 1, D J Rowbotham 1
PMCID: PMC1910113  PMID: 8019757

Abstract

1. The roles of both Ca2+ and adenosine 3':5'-cyclic monophosphate (cyclic AMP) in carbachol and K(+)-stimulated [3H]-noradrenaline release from SH-SY5Y human neuroblastoma cells were examined. 2. Both carbachol and K+ caused a time- and dose-related stimulation of [3H]-noradrenaline release. The release event in perfused cells was monophasic. Half-maximum stimulation measured in statically incubated (3 min) cells was 38 +/- 4 microM and 63 +/- 4 mM respectively. K+ (100 mM, added)-evoked release was greater than that produced by carbachol (1 mM). 3. Both carbachol and K+ caused a time- and dose (measured at 3 min)-related stimulation of cyclic AMP formation with half-maximum stimulation occurring at 5 +/- 1 microM and 49 +/- 2 mM respectively. In contrast to its effects on release, carbachol produced a greater stimulation of cyclic AMP formation than K+. 4. K(+)-stimulated [3H]-noradrenaline release was entirely dependent on Ca2+ entry as 2.5 mM Ni2+ abolished release. However, carbachol-evoked (1 mM) release appeared to be unaffected by Ni2+ pretreatment. 5. These data suggest that in SH-SY5Y cells, elevated cyclic AMP levels are not directly involved in [3H]-noradrenaline release. In addition, carbachol-stimulated release is largely independent of extracellular Ca2+ possibly implying a role for intracellular stored Ca2+ in the release process.

Full text

PDF
787

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appell K. C., Barefoot D. S. Neurotransmitter release from bradykinin-stimulated PC12 cells. Stimulation of cytosolic calcium and neurotransmitter release. Biochem J. 1989 Oct 1;263(1):11–18. doi: 10.1042/bj2630011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Atcheson R., Rowbotham D. J., Lambert D. G. Fentanyl inhibits the uptake of [3H]noradrenaline in cultured neuronal cells. Br J Anaesth. 1993 Oct;71(4):540–543. doi: 10.1093/bja/71.4.540. [DOI] [PubMed] [Google Scholar]
  3. Bowyer J. F., Weiner N. K+ channel and adenylate cyclase involvement in regulation of Ca2+-evoked release of [3H]dopamine from synaptosomes. J Pharmacol Exp Ther. 1989 Feb;248(2):514–520. [PubMed] [Google Scholar]
  4. Brown B. L., Albano J. D., Ekins R. P., Sgherzi A. M. A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate. Biochem J. 1971 Feb;121(3):561–562. doi: 10.1042/bj1210561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burgoyne R. D. Mechanisms of secretion from adrenal chromaffin cells. Biochim Biophys Acta. 1984 Jun 25;779(2):201–216. doi: 10.1016/0304-4157(84)90009-1. [DOI] [PubMed] [Google Scholar]
  6. Heijna M. H., Hogenboom F., Mulder A. H., Schoffelmeer A. N. Opioid receptor-mediated inhibition of 3H-dopamine and 14C-acetylcholine release from rat nucleus accumbens slices. A study on the possible involvement of K+ channels and adenylate cyclase. Naunyn Schmiedebergs Arch Pharmacol. 1992 Jun;345(6):627–632. doi: 10.1007/BF00164575. [DOI] [PubMed] [Google Scholar]
  7. Herdon H., Strupish J., Nahorski S. R. Differences between the release of radiolabelled and endogenous dopamine from superfused rat brain slices: effects of depolarizing stimuli, amphetamine and synthesis inhibition. Brain Res. 1985 Dec 2;348(2):309–320. doi: 10.1016/0006-8993(85)90450-0. [DOI] [PubMed] [Google Scholar]
  8. Illes P. Mechanisms of receptor-mediated modulation of transmitter release in noradrenergic, cholinergic and sensory neurones. Neuroscience. 1986 Apr;17(4):909–928. doi: 10.1016/0306-4522(86)90071-0. [DOI] [PubMed] [Google Scholar]
  9. Kazmi S. M., Mishra R. K. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells. Mol Pharmacol. 1987 Jul;32(1):109–118. [PubMed] [Google Scholar]
  10. Kazmi S. M., Mishra R. K. Identification of alpha 2-adrenergic receptor sites in human retinoblastoma (Y-79) and neuroblastoma (SH-SY5Y) cells. Biochem Biophys Res Commun. 1989 Feb 15;158(3):921–928. doi: 10.1016/0006-291x(89)92810-6. [DOI] [PubMed] [Google Scholar]
  11. Knight D. E., von Grafenstein H., Athayde C. M. Calcium-dependent and calcium-independent exocytosis. Trends Neurosci. 1989 Nov;12(11):451–458. doi: 10.1016/0166-2236(89)90095-7. [DOI] [PubMed] [Google Scholar]
  12. Lambert D. G., Atcheson R., Hirst R. A., Rowbotham D. J. Effects of morphine and its metabolites on opiate receptor binding, cAMP formation and [3H]noradrenaline release from SH-SY5Y cells. Biochem Pharmacol. 1993 Oct 5;46(7):1145–1150. doi: 10.1016/0006-2952(93)90462-6. [DOI] [PubMed] [Google Scholar]
  13. Lambert D. G., Challiss R. A., Nahorski S. R. Accumulation and metabolism of Ins(1,4,5)P3 and Ins(1,3,4,5)P4 in muscarinic-receptor-stimulated SH-SY5Y neuroblastoma cells. Biochem J. 1991 Feb 1;273(Pt 3):791–794. doi: 10.1042/bj2730791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lambert D. G., Ghataorre A. S., Nahorski S. R. Muscarinic receptor binding characteristics of a human neuroblastoma SK-N-SH and its clones SH-SY5Y and SH-EP1. Eur J Pharmacol. 1989 Jun 8;165(1):71–77. doi: 10.1016/0014-2999(89)90771-1. [DOI] [PubMed] [Google Scholar]
  15. Lambert D. G., Nahorski S. R. Muscarinic-receptor-mediated changes in intracellular Ca2+ and inositol 1,4,5-trisphosphate mass in a human neuroblastoma cell line, SH-SY5Y. Biochem J. 1990 Jan 15;265(2):555–562. doi: 10.1042/bj2650555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lambert D. G., Nahorski S. R. Pertussis toxin inhibits alpha 2-adrenoceptor-mediated inhibition of adenylate cyclase without affecting muscarinic regulation of [Ca2+]i or inositol phosphate generation in SH-SY5Y human neuroblastoma cells. Biochem Pharmacol. 1990 Nov 15;40(10):2291–2295. doi: 10.1016/0006-2952(90)90725-z. [DOI] [PubMed] [Google Scholar]
  17. Lambert D. G., Whitham E. M., Baird J. G., Nahorski S. R. Different mechanisms of Ca2+ entry induced by depolarization and muscarinic receptor stimulation in SH-SY5Y human neuroblastoma cells. Brain Res Mol Brain Res. 1990 Aug;8(3):263–266. doi: 10.1016/0169-328x(90)90026-a. [DOI] [PubMed] [Google Scholar]
  18. Miller R. J. Receptor-mediated regulation of calcium channels and neurotransmitter release. FASEB J. 1990 Dec;4(15):3291–3299. [PubMed] [Google Scholar]
  19. Mulder A. H., Schoffelmeer A. N., Stoof J. C. On the role of adenylate cyclase in presynaptic modulation of neurotransmitter release mediated by monoamine and opioid receptors in the brain. Ann N Y Acad Sci. 1990;604:237–249. doi: 10.1111/j.1749-6632.1990.tb31997.x. [DOI] [PubMed] [Google Scholar]
  20. Murphy N. P., Ball S. G., Vaughan P. F. Potassium- and carbachol-evoked release of [3H]noradrenaline from human neuroblastoma cells, SH-SY5Y. J Neurochem. 1991 May;56(5):1810–1815. doi: 10.1111/j.1471-4159.1991.tb02085.x. [DOI] [PubMed] [Google Scholar]
  21. Murphy N. P., McCormack J. G., Ball S. G., Vaughan P. F. The effect of protein kinase C activation on muscarinic-M3- and K(+)-evoked release of [3H]noradrenaline and increases in intracellular Ca2+ in human neuroblastoma SH-SY5Y cells. Biochem J. 1992 Mar 15;282(Pt 3):645–650. doi: 10.1042/bj2820645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Nakagawa-Yagi Y., Saito Y., Takada Y., Takayama M. Carbachol enhances forskolin-stimulated cyclic AMP accumulation via activation of calmodulin system in human neuroblastoma SH-SY5Y cells. Biochem Biophys Res Commun. 1991 Jul 15;178(1):116–123. doi: 10.1016/0006-291x(91)91787-d. [DOI] [PubMed] [Google Scholar]
  23. Neher E. Spatial and temporal aspects of Ca changes in secretion control. Biochem Soc Trans. 1993 May;21(2):420–423. doi: 10.1042/bst0210420. [DOI] [PubMed] [Google Scholar]
  24. Pelayo F., Dubocovich M. L., Langer S. Z. Possible role of cyclic nucleotides in regulation of noradrenaline release from rat pineal through presynaptic adrenoceptors. Nature. 1978 Jul 6;274(5666):76–78. doi: 10.1038/274076a0. [DOI] [PubMed] [Google Scholar]
  25. Ross R. A., Biedler J. L. Presence and regulation of tyrosinase activity in human neuroblastoma cell variants in vitro. Cancer Res. 1985 Apr;45(4):1628–1632. [PubMed] [Google Scholar]
  26. Ross R. A., Spengler B. A., Biedler J. L. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst. 1983 Oct;71(4):741–747. [PubMed] [Google Scholar]
  27. Schoffelmeer A. N., Hogenboom F., Mulder A. H. Evidence for a presynaptic adenylate cyclase system facilitating [3H]norepinephrine release from rat brain neocortex slices and synaptosomes. J Neurosci. 1985 Oct;5(10):2685–2689. doi: 10.1523/JNEUROSCI.05-10-02685.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Schoffelmeer A. N., Mulder A. H. [3H]noradrenaline release from brain slices induced by an increase in the intracellular sodium concentration: role of intracellular calcium stores. J Neurochem. 1983 Mar;40(3):615–621. doi: 10.1111/j.1471-4159.1983.tb08025.x. [DOI] [PubMed] [Google Scholar]
  29. Scott I. G., Akerman K. E., Heikkilä J. E., Kaila K., Andersson L. C. Development of a neural phenotype in differentiating ganglion cell-derived human neuroblastoma cells. J Cell Physiol. 1986 Aug;128(2):285–292. doi: 10.1002/jcp.1041280221. [DOI] [PubMed] [Google Scholar]
  30. Seward E., Hammond C., Henderson G. Mu-opioid-receptor-mediated inhibition of the N-type calcium-channel current. Proc Biol Sci. 1991 May 22;244(1310):129–135. doi: 10.1098/rspb.1991.0061. [DOI] [PubMed] [Google Scholar]
  31. Shuntoh H., Taniyama K., Fukuzaki H., Tanaka C. Inhibition by cyclic AMP of phorbol ester-potentiated norepinephrine release from guinea pig brain cortical synaptosomes. J Neurochem. 1988 Nov;51(5):1565–1572. doi: 10.1111/j.1471-4159.1988.tb01126.x. [DOI] [PubMed] [Google Scholar]
  32. Wemer J., Schoffelmeer A. N., Mulder A. H. Effects of cyclic AMP analogues and phosphodiesterase inhibitors on K+-induced [3H]noradrenaline release from rat brain slices and on its presynaptic alpha-adrenergic modulation. J Neurochem. 1982 Aug;39(2):349–356. doi: 10.1111/j.1471-4159.1982.tb03954.x. [DOI] [PubMed] [Google Scholar]
  33. Zucker R. S. Calcium and transmitter release at nerve terminals. Biochem Soc Trans. 1993 May;21(2):395–401. doi: 10.1042/bst0210395. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES